What is the RITA-T Screening Test
The RITA-T is a new Level 2 screening tests: it is to be administered on young children identified at risk for ASD, or who scored positive on a Level 1 screening test, or providers are worried about.
Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus
Currently the average age of diagnosis of Autism Spectrum Disorder in the US is close to 4 years of age
(signs can be seen as early as 12 months of age).
It is important to think of a new system and new way to identify early ASD:
To identify early to treat early and to change the course of the disorder and significantly reduce its impact.
This is an urgent public health need and not only in the US but globally.
The RITA-T will allow the screening and identification of toddlers as early as 18 months of age.
Join the RITA-T Team for our webinar training conducted through Zoom! Learn how to administer and integrate the screening tool into your practice!
For registration details and CME/CEU credit information, please see our event flyer!
Interested in attending? Here is our event page!
The RITA-T is a new Level 2 screening tests: it is to be administered on young children identified at risk for ASD, or who scored positive on a Level 1 screening test, or providers are worried about.
We have developed an online training program to improve access, while providing at same time educational material on early signs of autism, different models that have integrated the RITA-T.
Want to be part of our online community and contribute with your stories and experience?